U.S. Semiconductors Stock News

VeriSign, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year over year, while also announcing a quarterly dividend increase to US$0.81 per share and updating investors on progress under its long-running share repurchase program. Beyond the headline growth in revenue and earnings, the combination of a higher dividend and continued buybacks highlights management’s emphasis on returning cash to shareholders alongside its core internet...

Paramount Skydance (PSKY) has caught investor attention after its recent performance, with the share price last closing at US$11.01 and short term returns showing a mix of modest gains and declines across different time frames. See our latest analysis for Paramount Skydance. Those small recent share price gains, including a 1-day share price return of 1.57% and 7-day return of 2.42%, sit against a weaker backdrop, with a 30-day share price return showing a 9.38% decline and a 90-day share...

If you are wondering whether Neurocrine Biosciences is fairly priced or offering value right now, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$137.44, with returns of 3.6% over 30 days and 17.3% over 1 year. These figures can change how investors think about both its potential upside and its risk. Recent news coverage has focused on Neurocrine Biosciences as a key player in the US pharmaceuticals and biotech space, with...

If you are wondering whether Atlassian shares are starting to look interesting at today’s price, this article will walk through what the current market value actually reflects and what it might be missing. Atlassian’s share price closed at US$86.97, with returns of a 17.2% decline over 7 days, 40.6% decline over 30 days, 43.8% decline year to date and 72.7% decline over the past year. Even the 3 year and 5 year returns of 53.6% decline and 65.3% decline respectively show how much sentiment...

DexCom is rolling out new AI-driven upgrades to its Stelo glucose monitoring platform, including expanded Smart Food Logging tied to a broad nutrition database. The Stelo app is also adding a redesigned Daily Insights interface that offers personalized, coaching style guidance around food and lifestyle choices. These features are launching nationwide as part of DexCom's push to deepen engagement with consumer users of its glucose monitoring tools. For investors watching DexCom...

Boeing (NYSE:BA) reported a record January for aircraft orders and deliveries, outpacing Airbus. The company secured a long term C-17 modernization contract with the U.S. Air Force, with work planned through 2075. Boeing booked large commercial deals with customers including Delta Air Lines and Aviation Capital Group. The company is relocating jobs to South Carolina, triggering rising union concerns about possible layoffs. Boeing, a core player in global commercial aviation and defense, is...

If you are wondering whether Syndax Pharmaceuticals at US$21.71 is offering good value today, you are not alone. This article is here to unpack that question calmly and clearly. The stock has returned 6.3% over the last 7 days, 4.8% over 30 days, 1.9% year to date and 46.1% over the past year. However, the 3 year and 5 year returns of negative 16.5% and negative 5.0% show a more mixed longer term picture. These moves have arrived alongside ongoing interest in Syndax Pharmaceuticals' pipeline...

Mettler-Toledo International (MTD) has drawn investor interest after recent trading left the shares around $1,392.65, with a value score of 1 and mixed total returns over the past year and past 3 months. See our latest analysis for Mettler-Toledo International. With the share price at US$1,392.65, Mettler-Toledo’s recent 30 day share price return of a 6.66% decline and relatively flat 90 day move contrast with a 6.10% gain in 1 year total shareholder return and a 19.39% total shareholder...

How Avantor's FY 2025 Numbers Set the Stage for the Next Chapter Avantor (AVTR) just posted its FY 2025 third quarter results with revenue of US$1,623.8 million, a basic EPS loss of US$1.04 and net income loss of US$711.8 million, putting a sharp spotlight on profitability. The company has seen quarterly revenue move from US$1,714.4 million in Q3 2024 to US$1,686.6 million in Q4 2024, then to US$1,581.4 million and US$1,683.4 million in Q1 and Q2 2025, with EPS shifting from US$0.08 to...

Navitas Semiconductor (NVTS) has introduced a 10 kW all‑GaN DC‑DC power platform targeting next‑generation AI data centers, offering up to 98.5% peak efficiency, 1 MHz switching frequency, and high power density in a compact full‑brick module. See our latest analysis for Navitas Semiconductor. At a share price of $8.76, Navitas has had a mixed few months, with a 7 day share price return of 6.83% alongside a 30 day share price decline of 16.01%. Its 1 year total shareholder return of 207.37%...

If you are wondering whether Pathward Financial's current share price still offers value, it helps to first see how its market price lines up with what the business might be worth. The stock last closed at US$89.59, with returns of 21.8% over the past month, 24.7% year to date and 14.0% over the last year, which can change how investors think about both upside and risk. Recent news coverage has focused on Pathward Financial's position in the U.S. banking sector and how its business model...

Earlier in February 2026, Booking.com was named the Official Travel Partner of the Route 66 Centennial, integrating its platform across a year-long series of road-trip events along the historic highway as it nears its 100th anniversary. This partnership puts Booking.com at the heart of a high-visibility U.S. road-trip campaign, highlighting its end-to-end trip planning tools, flexible bookings, and broad lodging and car rental coverage along the full Route 66 corridor. Next, we’ll examine...

If you are wondering whether Nu Holdings is still good value after its strong run, you are not alone. The stock has quickly become a talking point for many growth focused investors. The share price recently closed at US$17.41, with total returns of 2.3% over the past week, 2.2% over the past month, 2.3% year to date and 27.6% over the last year, while the 3 year return sits at 232.3%. This naturally raises questions about what is already priced in. Recent news flow has centered on Nu...

UnitedHealth Group (NYSE:UNH) is under heightened regulatory scrutiny over Medicare Advantage payment practices following a Senate Finance Committee report. The company is shifting its focus to margin instead of growth as it responds to a tougher reimbursement backdrop and closer oversight. Management is guiding for the first annual revenue decline in decades, citing adverse Medicare policy proposals. UnitedHealth Group sits at the center of US managed care, with Medicare Advantage a key...

Federal National Mortgage Association (FNMA) has just posted its FY 2025 third quarter numbers, with revenue of US$7.0b and EPS of US$0.66 setting the tone for the latest update. Over recent quarters, revenue has moved from US$8.0b in FY 2024 Q2 to US$7.4b in Q3 and US$7.8b in Q4, then to US$7.2b in FY 2025 Q1, US$6.5b in Q2 and US$7.0b in Q3. EPS has ranged from US$1.50 in FY 2024 Q2 and US$0.69 in Q3 to close to zero in late 2024 and early 2025, before landing at US$1.19 in FY 2025 Q2 and...

If you are wondering whether Universal's share price reflects what the business is worth, or if the market is overlooking something important, this article is for you. The stock last closed at US$52.87, with returns of a 10% decline over 7 days, a 2.6% decline over 30 days, 0.6% year to date, 4.8% over 1 year, 19.1% over 3 years and 36.7% over 5 years. Recent share price moves have brought Universal back onto investors' radar, especially for those reassessing risk and reward at current...

Latest Earnings Snapshot Tower Semiconductor (NasdaqGS:TSEM) has posted its FY 2025 third quarter numbers with revenue of US$395.7 million and basic EPS of US$0.48, giving investors a clear read on how the year is shaping up. The company has seen revenue move from US$351.2 million in Q2 2024 to US$395.7 million in Q3 2025, while quarterly basic EPS has ranged from US$0.48 to US$0.49 over that period, alongside trailing 12 month revenue of about US$1.5 billion and basic EPS of roughly US$1.75...

D.R. Horton recently opened its Stanton community in Richburg, South Carolina, offering ranch and two-story smart homes with amenities such as pickleball courts, a pool, and playgrounds, and convenient access to the Charlotte area. At the same time, reports of a possible U.S. Department of Justice antitrust probe into information-sharing among major builders, including D.R. Horton, have added legal and regulatory uncertainty around industry practices and housing costs. We’ll now examine how...

In early February 2026, Expro unveiled Solus™, a high-debris single shear and seal ball valve system that replaces traditional two-valve subsea well access configurations, offering enhanced safety, flexibility, and reduced complexity for offshore oil and gas operations. By combining shear-and-seal capability in a single NACE-compliant valve already deployed in the Gulf of Mexico and the North Sea, Solus™ underscores Expro’s push toward more efficient subsea intervention and well abandonment...

If you are wondering whether SM Energy is attractively priced or just a value trap, this article will walk through what the current share price really reflects. The stock last closed at US$21.90, with returns of 9.3% over the past week, 22.6% over the past month, 14.5% year to date, and a 41.6% decline over the past year. Taken together, these figures give mixed signals about how the market currently views its prospects and risk. Recent coverage of SM Energy has focused on its position in...

Earlier this week, Community Health Accreditation Partner (CHAP) awarded Aveanna Home Health and Hospice a Disease Program Certification for Heart Failure, recognizing compliance with nationally accepted quality metrics and advanced clinician education standards across its Heartways program. This certification highlights Aveanna’s emphasis on specialized, clinically rigorous heart failure care in the home setting, which could strengthen its position with patients, payers, and referral...

Why Philip Morris International (PM) Is Back in Focus After Its Latest Earnings Philip Morris International (PM) is back on many investors radar after reporting fourth quarter and full year 2025 results, raising 2026 EPS growth guidance, and highlighting the growing role of smoke free products. See our latest analysis for Philip Morris International. The earnings beat, higher 2026 EPS growth guidance and growing share of smoke free products have coincided with a 12.78% 1 month share price...

The Coca-Cola Company has released its fourth-quarter and full-year 2025 results, reporting Q4 sales of US$11,822 million and net income of US$2,271 million, alongside a near US$1 billion impairment on its BodyArmor sports drink brand. The update also confirmed a leadership handover from CEO James Quincey to Henrique Braun and set 2026 guidance for 4% to 5% organic revenue growth and 7% to 8% comparable earnings growth, framing how the business plans to respond to mixed regional trends and...

Duke Energy (NYSE:DUK) reported annual results that surpassed its previously issued 2025 earnings guidance. The company outlined a five year capital plan of US$103b focused on energy infrastructure, grid upgrades, and renewable projects. Duke Energy extended its long term earnings growth guidance through 2030, signaling management confidence in its investment program. Duke Energy is one of the largest regulated utilities in the US, supplying electricity and gas across several states. For...